A novel nanoparticle platform that can efficiently deliver clinically important proteins in vivo in initial proof-of-concept tests has been successfully developed by a research team led by Brigham and Women's Hospital (BWH). Nanoparticles, which are particles measuring nanometers in size, hold promise for a range of applications, including human therapeutics. The key advantage of the new platform, known as a thermosponge nanoparticle, is that it eliminates the need ...
via Medindia Health News More READ
via Medindia Health News More READ
No comments:
Post a Comment